Tumor vascular responses to antivascular and antiangiogenic strategies: looking for suitable models
Jihane Mriouah, Cédric Boura, Magalie Thomassin, Thierry Bastogne, Dominique Dumas, Béatrice Faivre, Muriel Barberi-Heyob. Antiangiogenic and vascular disrupting agents are in the current cancer therapeutic armamentarium. A better understanding of the intricate mechanisms ruling neovessel survival within tumors during....
Subscribe to LegalLaw247.Com Newsletter